GR3019859T3 - Synthetic vaccine for the specific induction of cytotoxic T-lymphocytes - Google Patents

Synthetic vaccine for the specific induction of cytotoxic T-lymphocytes

Info

Publication number
GR3019859T3
GR3019859T3 GR960401244T GR960401244T GR3019859T3 GR 3019859 T3 GR3019859 T3 GR 3019859T3 GR 960401244 T GR960401244 T GR 960401244T GR 960401244 T GR960401244 T GR 960401244T GR 3019859 T3 GR3019859 T3 GR 3019859T3
Authority
GR
Greece
Prior art keywords
lymphocytes
cytotoxic
specific induction
synthetic vaccine
killer
Prior art date
Application number
GR960401244T
Other languages
English (en)
Inventor
Guenther Jung
Hans-Georg Rammensee
Karl Deres
Karl-Heinz Wiesmueller
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6393249&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3019859(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of GR3019859T3 publication Critical patent/GR3019859T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6018—Lipids, e.g. in lipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GR960401244T 1989-11-10 1996-05-07 Synthetic vaccine for the specific induction of cytotoxic T-lymphocytes GR3019859T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3937412A DE3937412A1 (de) 1989-11-10 1989-11-10 Synthetische vakzine zur spezifischen induktion zytotoxischer t-lymphozyten

Publications (1)

Publication Number Publication Date
GR3019859T3 true GR3019859T3 (en) 1996-08-31

Family

ID=6393249

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960401244T GR3019859T3 (en) 1989-11-10 1996-05-07 Synthetic vaccine for the specific induction of cytotoxic T-lymphocytes

Country Status (9)

Country Link
EP (1) EP0431327B2 (el)
JP (1) JP3057748B2 (el)
AT (1) ATE137118T1 (el)
DE (2) DE3937412A1 (el)
DK (1) DK0431327T4 (el)
ES (1) ES2087111T5 (el)
GR (1) GR3019859T3 (el)
IE (1) IE74899B1 (el)
PT (1) PT95824B (el)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6607727B1 (en) 1991-08-26 2003-08-19 The Scripps Research Institute Peptides for inducing cytotoxic T lymphocyte responses to hepatitus B virus
US5780036A (en) * 1991-08-26 1998-07-14 The Scripps Research Institute Peptides for inducing cytotoxic T lymphocyte responses to hepattis B virus
US6419931B1 (en) 1991-08-26 2002-07-16 Epimmune Inc. Compositions and methods for eliciting CTL immunity
US6322789B1 (en) 1991-08-26 2001-11-27 Epimmune, Inc. HLA-restricted hepatitis B virus CTL epitopes
CA2081952A1 (en) * 1991-11-08 1993-05-09 John J. Donnelly Recombinant dna sequences and plasmids for cellular immunity vaccines from bacterial toxin-antigen conjugates, and methods of their use
CA2085083A1 (en) * 1991-12-18 1993-06-19 Richard L. Tolman Synthetic peptides comprising a cyclic hiv principal neutralizing determinant and a lipopeptide
US6235288B1 (en) 1992-08-26 2001-05-22 The Scripps Research Institute Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus
BR9709993A (pt) 1996-06-25 1999-08-10 Stichting Inst Dierhouderij Vacina preparação de vacina composição processo para produção de uma preparação imugênica e preparação imugênica
US6977074B2 (en) 1997-07-10 2005-12-20 Mannkind Corporation Method of inducing a CTL response
US6861234B1 (en) 2000-04-28 2005-03-01 Mannkind Corporation Method of epitope discovery
US8637305B2 (en) 2001-11-07 2014-01-28 Mannkind Corporation Expression vectors encoding epitopes of target-associated antigens and methods for their design
AU2011232421B2 (en) 2010-03-23 2015-08-13 Novartis Ag Compounds (cystein based lipopeptides) and compositions as TLR2 agonists used for treating infections, inflammations, respiratory diseases etc.
NL2007536C2 (en) 2011-10-05 2013-04-08 Academisch Ziekenhuis Leiden Lumc Adjuvant compound.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2401173A1 (fr) * 1977-06-27 1979-03-23 Roussel Uclaf Nouveaux steroides, leur procede de preparation et leur application dans la synthese de steroides marques au tritium
EP0203676B1 (en) * 1985-04-19 1992-01-29 The Wistar Institute Of Anatomy And Biology Vaccine for generating an immunogenic t cell response protective against a virus
DE3546150A1 (de) * 1985-06-24 1987-01-22 Hoechst Ag Membrananker-wirkstoffkonjugat, seine herstellung sowie seine verwendung
DE3813821A1 (de) * 1988-04-22 1989-11-02 Hoechst Ag Synthetische vakzine gegen die maul- und klauenseuche und verfahren zu deren herstellung
AU2914889A (en) * 1987-08-28 1989-04-17 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome
AU4030989A (en) * 1988-02-12 1989-09-06 Regents Of The University Of California, The Use of synthetic peptides to generate and manipulate cellular immunity

Also Published As

Publication number Publication date
EP0431327B2 (de) 2001-04-04
ES2087111T3 (es) 1996-07-16
IE74899B1 (en) 1997-08-13
EP0431327A1 (de) 1991-06-12
JPH0454131A (ja) 1992-02-21
EP0431327B1 (de) 1996-04-24
DK0431327T3 (da) 1996-08-12
PT95824A (pt) 1991-09-13
JP3057748B2 (ja) 2000-07-04
DE59010300D1 (de) 1996-05-30
DE3937412A1 (de) 1991-05-16
ES2087111T5 (es) 2001-06-16
IE904051A1 (en) 1991-05-22
DK0431327T4 (da) 2001-06-18
ATE137118T1 (de) 1996-05-15
PT95824B (pt) 2001-04-30

Similar Documents

Publication Publication Date Title
IL102687A (en) Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
GR3019859T3 (en) Synthetic vaccine for the specific induction of cytotoxic T-lymphocytes
EP0523395A3 (el)
DE69840383D1 (de) Ctl epitope des epstein-barr virus
AU1955088A (en) Avirulent microbes, incapable of producing functional adenylate cyclase and cyclic AMP
EP0429477A4 (en) Synthetic vaccine against aids virus
GEP20032902B (en) Mixture of Recombinant Vaccinia Vectors as Polyenv Vaccines for HIV
RU94042386A (ru) Вакцина против гепатита, содержащая 3-0-дезацилированный монофосфорил-липида, применение антигена гепатита для получения препарата для лечения гепатита, способ лечения гепатита
AU1380788A (en) Synthetic peptide antigens for the detection of hiv-1 infection
NO912825D0 (no) Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper.
PL303482A1 (en) Vaccine against infection with streptococcus suis, streptococcus suis polypeptide and method of preparing such vaccine
AU4596397A (en) Rotavirus vaccine formulations
HUP9801266A2 (hu) Multimer, rekombináns ureázvakcina
TW377373B (en) Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease
NL300336I1 (nl) Vaccin tegen de bof dat een jeryl-lynn virusstam bevat
AU635083B2 (en) Purification of b.pertussis toxin and filamentous hemagglutinin antigen
IL93599A0 (en) Kit and/or composition for the prevention or treatment of aids
SE9604322D0 (sv) Bacterial antigens and vaccine compositions II
ZA888580B (en) New immunologically active synthetic peptides useful for preparing an antimalarial vaccine